# HAS certification: the buying signal your CRM misses

French hospitals’ HAS certification and IQSS scores are public. A facility certified with conditions revisits its quality priorities within 6 to 24 months: a buying window that Apollo and Sales Navigator can’t see.

URL: https://agify-md.fr/en/medify/certification-has-signal-achat/

Every year, roughly €700 million is redistributed to French healthcare facilities based on their results on quality indicators. That’s the budget of the IFAQ program, and it’s calculated from scores that are entirely public.

For a MedTech sales rep, those scores aren’t an administrative detail. The HAS (Haute Autorité de Santé, France’s National Authority for Health) evaluates every facility every 4 years and publishes its decision: certified with distinction, certified, certified with conditions, or not certified. A facility rated “with conditions” must fix its gaps and undergo a new full visit within 6 to 24 months. That’s a dated buying window, visible to everyone, and missing from most sales CRMs.

This article explains what the HAS quality overview contains, how to read a certification decision as a buying signal, where to find hospital-by-hospital scores, and how to turn that reading into a sales pipeline.

## What is HAS certification, in practice?

HAS certification is a mandatory external assessment of the quality and safety of care, carried out by the Haute Autorité de Santé for every French healthcare facility. It results in one of four decisions: certified with distinction, certified, certified with conditions, or not certified. The cycle runs every 4 years, and a 6th cycle opened in 2025. At the end of 2024, 87% of the facilities assessed were certified.

Certification isn’t just a pass/fail label. It’s based on a detailed framework (the current version was adopted by decision of the HAS board on November 20, 2024) that covers patient care, governance, and the facility’s improvement dynamics.

Two validity periods coexist, and that’s where the signal hides. A “certified” or “certified with distinction” decision is valid for 4 years, until the next visit. A “certified with conditions” or “not certified” decision, on the other hand, triggers a new full visit within 6 to 24 months. The facility enters an active upgrade phase, on a tight timeline.

## What does a facility “certified with conditions” tell a sales rep?

A facility certified with conditions is signaling that it must fix identified quality gaps and will be reassessed within 6 to 24 months. In practice, its leadership has an explicit mandate: demonstrate measurable improvement before the next visit. Any product or service that helps close a documented gap (traceability, medication-use safety, patient records, healthcare-associated infections) meets demand that’s already budgeted and already prioritized internally.

It’s the opposite of a cold call. You don’t have to create the need; a public authority has set it, with a deadline. Sales work shifts from persuasion to timing and relevance: identifying which facilities are under conditions, on which criterion, and which contact owns the action plan.

The decision can also be read in reverse. A low score on a specific indicator isn’t just a bad grade: it’s a named target for the vendor whose product addresses that indicator. That’s exactly the reading Agify builds into Radar’s sourcing for its MedTech clients.

## Where can you find quality scores for French hospitals?

Quality scores for healthcare facilities are public and available on QualiScope, the publishing platform of the [Haute Autorité de Santé](https://www.has-sante.fr), as well as in open data. They come from the national program of quality and safety of care indicators (IQSS), which measures themes that are comparable from one facility to the next.

These indicators include the satisfaction and experience of hospitalized patients (e-Satis), consumption of alcohol-based hand rub as a marker of infection prevention (ICSHA), and the quality of patient record keeping. Each indicator is calculated using a published method, which makes the results comparable and usable at the national level.

For a sales rep, the value isn’t in an isolated score but in the cross-reference. A facility with a weak indicator on a theme your product addresses, located in your territory, with a certification visit coming up, is a highly relevant target. Once the target is set, the [RPPS lets you trace back to the practitioner who makes the decision](https://agify-md.fr/en/medify/rpps-ciblage-medtech/) by specialty and facility. The data exists; what most teams lack is systematic aggregation.

## Why does the IFAQ turn a HAS score into a budget?

The IFAQ (incitation financière à l’amélioration de la qualité, a financial incentive for quality improvement) ties quality scores directly to facility funding. Run by the DGOS (the French health ministry’s directorate for healthcare provision), the program redistributes a national budget of roughly €700 million (2024 amount, maintained in 2025), or nearly 1% of facility funding, based on their results and their progress on mandatory indicators.

This mechanism changes the nature of the signal. A poor score isn’t just a reputational risk: it’s a concrete, recurring financial loss for acute care (MCO), home hospitalization (HAD), post-acute and rehabilitation care (SMR), dialysis, and psychiatric facilities. The pressure to invest in quality is therefore structural, not optional.

For a supplier, this means a facility with a low score on an indicator has a quantified interest in improving. Quality-based regulation creates demand backed by budget, and that demand can be read in advance in public data that neither Apollo, Sales Navigator, nor ZoomInfo integrates.

## How does a MedTech sales rep turn the HAS overview into pipeline?

Turning the HAS overview into pipeline means cross-referencing three layers: the certification decision (who is under conditions, with what deadline), IQSS scores by indicator (who is weak, and on what), and the facility’s identifier in FINESS (France’s national registry of healthcare facilities) to attach contacts and activity. The result is a list of accounts prioritized by real signals, not by size or geographic proximity alone.

A concrete example makes the point. A French healthcare messaging platform wanted to give its sales reps a complete view of the private clinic market. Agify scraped the entire HAS quality overview, 4,342 French clinical facilities, with each one’s certification status, scores by criterion, certification date (to anticipate renewals), and 4 to 5 enriched decision-makers. Facilities certified with conditions were flagged as priority targets: they’re the ones with an action plan underway and a tight timeline. The details of this mapping, from the HAS database to enriched contacts, are covered in [the case of 4,342 clinics targeted in nine days](https://agify-md.fr/en/medify/donnees-has-cibler-cliniques/).

The same signal logic shapes [buying-signal prospecting in the hospital market](https://agify-md.fr/en/medify/prospection-medtech-france/), and it shows up again in [a case of qualifying radiologists through public sources](https://agify-md.fr/en/medify/prospection-radiologues-imagerie/): you detect the need before pushing the message. If you’d like to see what this reading looks like applied to your catalog and your territory, book a [prospecting scoping call](https://cal.com/team/agify/audit-prospection-medtech?utm_source=agify-md.fr&utm_medium=site&utm_campaign=article-medify&utm_content=appel-section).

This approach extends beyond healthcare: wherever a regulator publishes scores, authorizations, or deadlines, there’s a readable buying calendar. That’s also true of public procurement, where [a BOAMP notice reveals six buying signals](https://agify-md.fr/en/medify/signaux-appel-offres-boamp/) to anyone who reads it like a sales rep, and of medical devices themselves, whose [registries track every step, from CE marking to EUDAMED registration](https://agify-md.fr/en/medify/signaux-reglementaires-medtech/). The HAS overview is simply one of the richest, because it combines a dated decision, granular scores, and funding tied to them.

## Frequently asked questions

### Is HAS certification mandatory for all facilities?

Yes. Certification is mandatory for all French healthcare facilities, public and private alike. It’s carried out by the Haute Autorité de Santé on a 4-year cycle. A 6th cycle opened in 2025. The results of every visit are made public, which makes them a usable source for qualifying a market.

### What’s the difference between HAS certification and IQSS indicators?

Certification is the overall decision on a facility’s quality (certified, with conditions, not certified), issued every 4 years. IQSS indicators are thematic, quantified measures (patient satisfaction, infections, patient records) collected more frequently and published on QualiScope. The two complement each other: certification sets the direction, and the IQSS provide the detail by criterion.

### Is a facility “certified with conditions” a good prospect?

Often, yes, for a supplier whose product addresses the gap that was found. That facility has a mandate to upgrade and a new visit within 6 to 24 months. The need is established and the timeline is tight, which shortens the decision cycle compared with a cold approach with no signal.

### Is it legal to use this data for prospecting?

Yes. HAS certification data and IQSS indicators are public and released as open data. Using them to build sales targeting falls under legitimate interest within the meaning of the GDPR, provided you respect individuals’ rights regarding the associated contact data. The source itself is open and official.

### Why don’t tools like Apollo or Sales Navigator see these signals?

Because those tools cover LinkedIn profiles and generic company data, not French healthcare regulatory registries. HAS certification, IQSS, FINESS, and [BOAMP tenders detected early](https://agify-md.fr/en/medify/appel-offres-boamp-amont/) aren’t integrated into any standard outbound stack, and [even Sales Navigator’s Buyer Intent stays blind to these public buying windows](https://agify-md.fr/en/medify/sales-navigator-medtech-signal-achat/). That blind spot is precisely what makes reading public healthcare sources a defensible sales advantage.

## Conclusion

The HAS quality overview isn’t a compliance document reserved for hospital leadership. It’s a map of dated, public buying signals. A “certified with conditions” decision announces an upgrade within 6 to 24 months; a low IQSS score points to a specific need; and the IFAQ, with its €700 million, ties that need to a real budget.

The advantage doesn’t come from access to the data, which is open, but from aggregating it systematically and reading it against your catalog. That’s what Agify equips its MedTech clients to do with Radar. To scope this reading for your market, [let’s discuss your priority targets in 30 minutes](https://cal.com/team/agify/audit-prospection-medtech?utm_source=agify-md.fr&utm_medium=site&utm_campaign=article-medify&utm_content=appel-section).

---

*Agify is an AI agency specializing in MedTech prospecting and the use of French public healthcare sources. We build targeting engines that cross-reference regulatory registries, buying signals, and contact data for sales teams in the sector.*